2Bruinstroop E, van de Roe MA, Huisman MV. The use of D- dimer in specific clinical conditions;a narrative review[J]. ELtr J Intem Med, 2009,20:441-446.
3Hirsh J. The eighth ACCP conference on guideline for antithrombotic therapy[J]. US A: BC Decker Inc,2008:53 - 60.
4Wu C, Bates SM. Should D - dimer testing be used to predict the risk of recurrence after discontinuation of anticoagulant therapy for a first unprovoked episode of venous thromboembohsm[ J]. Pol Arch Med Wewn, 2009, 119;225 - 230.
5von Kanel R, Bellingrath S, Kudelka BM. Association of vital exhaustion and depressive symptoms with changes in fibrin D - dimer to acute psychosocial stress[J]. J Psychosom Res, 2009,67:93- 101.
6Haouzir S, Lemoine X, Desbordes M, et al. The role of coagulation marker fibrin D-dimer in early diagnosis of catatonia[J]. Psychiatry Res, 2009,168:78 - 85.
7Nadir Y, Hoffman R, Brenner B. Drug- related thrombosis in hematologic malignancies[J]. Rev Clin Exp Hematol, 2004,8:E4.
8Phrommintikul A, Haas S J, Elsik M, et al. Mortality and target haemoglobin concetrat ions in anaemic patients with chronic kidney disease treated with erythropoietin: a meta-analysis[J]. Lancet, 2007, 369:381 - 388.
9Canales MA, Arrieta R, Gomez- Rioja R, etal. Induction of a hypercoagulability state and endothelial cell activation by granulocyte colony -stimulating factor in peripheral blood stem cell donors [J]. J Hematother Stem Cell Res,2002,11:675- 681.
